Addex Therapeutics Ltd. balance sheet

At the end of fiscal 2025, Addex Therapeutics Ltd. had total assets of $8.0m and shareholders' equity of $6.0m. It held $2.1m in cash against $0 of debt: net cash of $2.1m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Addex Therapeutics Ltd.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	32	33	21	22	8	5	4	2
Receivables	0	0	0	0	0	0	0	0
Total current assets	43	33	22	24	8	5	4	2
Total assets	43	34	23	25	9	6	12	8
Total current liabilities	2	6	4	5	4	3	1	2
Long-term debt	0	0	0	0	0	0	0	0
Total debt	0	0	0	0	0	0	0	0
Shareholders' equity	40	26	17	19	5	1	11	6
Net debt (negative = net cash)	−32	−33	−21	−22	−8	−5	−4	−2
Shares outstanding	—	—	—	—	—	—	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ADXN vs LYEL ADXN vs AIM ADXN vs IBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Addex Therapeutics Ltd.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Addex Therapeutics Ltd.